$INAB
In8bio, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · New York, NY
INAB chart
What traders are saying about $INAB
Latest postsIn8bio, Inc. news
- IN8bio, Inc. Estimates – NASDAQ:INAB
TradingView ·
- IN8bio (INAB) Stock Price, News & Analysis
MarketBeat ·
- IN8bio, Inc. (6JH0.F) Insider Ownership & Holdings - Yahoo Finance
Yahoo! Finance Canada ·
- IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- IN8bio to Present at Sidoti Small-Cap Virtual Conference
Yahoo Finance ·
- IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
- IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development
Yahoo Finance ·
- IN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Yahoo Finance ·
- IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma
Yahoo Finance ·
- IN8bio (INAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Yahoo Finance ·
- IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026
Yahoo Finance ·
- IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma
Yahoo Finance ·
In8bio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$19.4M | -$30.4M | -$30.0M | -$28.5M |
| Diluted EPS | $-4.44 | $-17.05 | $-1.00 | $-1.36 |
| Total assets (year end) | $32.3M | $20.9M | $33.7M | $33.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About In8bio, Inc.
- Ticker
- INAB (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1740279
- Former names
- Incysus Therapeutics, Inc.
Frequently asked questions
What exchange is In8bio, Inc. listed on?
In8bio, Inc. trades on the Nasdaq under the ticker symbol INAB.
What industry is In8bio, Inc. in?
In8bio, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is In8bio, Inc. headquartered?
In8bio, Inc.'s business address on file with the SEC is in New York, NY.
When does In8bio, Inc.'s fiscal year end?
In8bio, Inc.'s fiscal year ends on December 31.